In 2024, UAB "Imunovakcina" had revenue of 151 thousand EUR.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 151k € | 0 € | 0 € |
Profit | - -100.0% | 19,7k € +141.6% | -47,5k € -229.0% |
Assets | - | - | - |
Liabilities | - | - | - |
Equity | - +100.0% | -27,2k € +42.1% | -46,9k € |
Employees | - | - | - |
Overall rating | B68/100 |
Financial health | 50/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity | 60/100 |
| Overall risk | Medium |
No risk flags | |
Possible tax debts | |
No financial data available | |
Regular report filing | |
| Description | Registered |
|---|---|
| CEO (Female) |
UAB "Imunovakcina" is located at Vilnius, Paribio g. 25B-6, LT-08102, LT-LT-08102.
The shareholders of UAB "Imunovakcina" include 2 Lithuanian legal entities. View ownership details →
Yes, UAB "Imunovakcina" is registered as an active VAT payer with VAT number LT100016367212.
UAB "Imunovakcina" was founded on February 23, 2021. The company has been operating for 5 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 5 years | 82 - 86 | 27% | |
Net revenue | 150 982,00 € | 35 - 39 | 68% | |
Registered capital | 15 000,00 € | - | 90% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Registered in the Lithuanian register of legal entities.